Pharma has been embracing AI in areas like clinical development and manufacturing, but adoption in market access has been slow. Is this about to change? Emma and Manca, two of our experienced market access specialists, discuss AI’s timely arrival into the market access space and where it could make a difference and help get products to patients faster.

“In patient engagement, we need to be asking ourselves, what more can we do?”

In her conversation with us at the Amiculum booth during MAPS EMEA, Trishna highlighted how medical affairs can lead the way – by involving patients from the outset, from trial design to informed consent and beyond. We couldn’t agree more!

Thank you, Trishna, for sharing your insights and helping drive the conversation forward.

Think strategy comes down the line when you’re approaching launch? We find that often, strategic planning is left too late, or the same barriers stall progress. James and Zoë discuss how early strategic planning can make an impact and how to avoid some of the common pitfalls.